Articles

Join Prospection

Passionate about health data and technology?

Stay up-to-date with the latest Prospection news and publications

Are high coronary risk patients missing ou...

To examine whether high coronary risk patients in Australia, where use of lipid-lowering drugs (LLD) is very high by international standards, are receiving LLD.

A retrospective review of the persistence ...

Aim: To describe the persistence of biologic disease modifying anti-rheumatic drugs (bDMARDs) in Australian rheumatoid arthritis (RA) patients, and assess the influence of methotrexate and other conventional DMARD (cDMARD) concomitant me...

Patterns of Antipsychotic Medication Presc...

Schizophrenia is a mental health disorder characterised by hallucinations, delusions and disorganised behaviour. The Australian pharmaceutical benefits scheme (PBS) reimburse a number of antipsychotic therapies, however, there is little...

Treatment persistence of subcutaneous TNF ...

Introduction: To describe the persistence of treatment with subcutaneous tumor necrosis factor inhibitors (TNFi) adalimumab, etanercept, and golimumab in immune-mediated rheumatic dis- ease (rheumatoid arthritis, psoriatic arthritis, and...

Long-term persistence with single-pill, fi...

To study treatment persistence and mortality using a single-pill, fixed-dose combination tablet compared with a two-pill combination for hypertension.

Be the first to know!

Sign up for our newsletter